Selected Publications

Bhutani DL, Ross AG, Lehman AY, Shindler KS: Resolution of COVID-19 induced anosmia following treatment with ST266. Otolaryngol Case Rep Nov 2022.

Ross AG, Higginbotham EJ: Unpacking the Barriers to Medication Adherence May Move Us Closer to Eye Health Equity. JAMA Ophthalmol 140(4), Apr 2022.

3. Elam AR, Tseng VL, Rodriguez TM, Mike EV, Warren AK, Coleman AL: American Academy of Ophthalmology Taskforce on Disparities in Eye Care. Disparities in Vision Health and Eye Care. Ophthalmology 129(10), 2022.

Capó H, Edmond JC, Alabiad CR, Ross AG, Williams BK, Briceño CA: The Importance of Health Literacy in Addressing Eye Health and Eye Care Disparities. Ophthalmology 129(10), 2022.

Shindler RE, Yue J, Chaqour B, Shindler KS, Ross AG: Repeat Brn3a immunolabeling rescues faded staining and improves detection of retinal ganglion cells. Exp Eye Res 15(226), 2022.

18. Ross AG, Chaqour B, McDougald DS, Dine KE, Duong TT, Shindler RE, Yue J, Liu T, Shindler KS: Selective Upregulation of SIRT1 Expression in Retinal Ganglion Cells by AAV-Mediated Gene Delivery Increases Neuronal Cell Survival and Alleviates Axon Demyelination Associated with Optic Neuritis. Biomolecules 12(6), 2022.

Ross AG, McDougald DS, Khan RS, Duong TT, Dine KE, Aravand P, Bennett J, Chavali VRM, Shindler KS: Rescue of retinal ganglion cells in optic nerve injury using cell-selective AAV mediated delivery of SIRT1. Nature Gene Therapy February 2021.

Reggie SN, Avery RA, Bavinger JC, Jivraj I, Alfaro C, Pistilli M, Kohli AA, Liu GT, Shindler KS, Ross AG, Kardon RH, Sibony PA, Tamhankar M: The sensitivity and specificity of retinal and choroidal folds to distinguish between mild papilloedema and pseudopapilledema. Eye (London) January 2021.

Khan RS, Ross AG, Aravand P, Dine K, Selzer EB, Shindler KS: RGC and Vision Loss From Traumatic Optic Neuropathy Induced by Repetitive Closed Head Trauma Is Dependent on Timing and Force of Impact. Transl Vis Sci Technol. 10(1), January 2021.

Khan RS, Ross AG, Willett K, Dine K, Banas R, Brown LR, Shindler KS: Amnion-Derived Multipotent Progenitor Cells Suppress Experimental Optic Neuritis and Myelitis. Neurotherapeutics 18(1): 448-459, Jan 2021.